The Knesset Labor, Welfare and Health Committee and the Committee for Advancing the Status of Women issued a call for the Gynecologists' Union to formulate recommendations for examinations to detect excessive blood clotting associated with use of the Yasmin and Yaz birth-control pills, the most popular brand in Israel. The committees called for those tests to be included in the basket of subsidized treatments and drugs. They also called on women's doctors to warn their patients about the dangers of the drugs.
The recommendation followed an urgent hearing by the two committees, in the wake of a report released last month by the United States Food and Drug Administration which showed a 75-percent increased risk of dangerous blood clots from the newer pills, which contain drospirenone than from older levonorgestrel. A British Medical Journal report showed a 50-percent increased risk.